{"id":"https://openalex.org/W64494153","doi":null,"title":"Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.","display_name":"Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.","publication_year":1997,"publication_date":"1997-07-01","ids":{"openalex":"https://openalex.org/W64494153","mag":"64494153","pmid":"https://pubmed.ncbi.nlm.nih.gov/11322272"},"language":"en","primary_location":{"id":"pmid:11322272","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11322272","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108527795","display_name":"Dominique Mathez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134648","display_name":"H\u00f4pital Raymond-Poincar\u00e9","ror":"https://ror.org/03pef0w96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210134648"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D Mathez","raw_affiliation_strings":["Unite d'Immunovirologie, H pital Raymond Poincar\u00e9, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unite d'Immunovirologie, H pital Raymond Poincar\u00e9, Paris, France","institution_ids":["https://openalex.org/I4210134648"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P Bagnarelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Bagnarelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109065393","display_name":"Isabelle Gorin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Gorin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017386021","display_name":"Christine Katlama","orcid":"https://orcid.org/0000-0002-5093-4800","observed_orcids":["https://orcid.org/0000-0002-5093-4800"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Katlama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105785204","display_name":"Gilles Pialoux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Pialoux","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114002044","display_name":"Gerard Saimot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Saimot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030892494","display_name":"P. Tubiana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Tubiana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108106807","display_name":"P. de Truchis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P De Truchis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110263077","display_name":"Jean Paul Chauvin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J P Chauvin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111802609","display_name":"Ray Mills","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Mills","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108198945","display_name":"Richard A. Rode","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Rode","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004847381","display_name":"Massimo Clementi","orcid":"https://orcid.org/0000-0002-7461-5898","observed_orcids":["https://orcid.org/0000-0002-7461-5898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Clementi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110027022","display_name":"Jacques Leibowitch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Leibowitch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0804,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.93761786,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"2","issue":"3","first_page":"175","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7261000275611877,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7261000275611877,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.260699987411499,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.984000027179718},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":0.8820000290870667},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/zalcitabine","display_name":"zalcitabine","score":1.0},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.7419999837875366},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.9480000138282776},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.8159999847412109},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.949999988079071},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9150000214576721},{"id":"https://openalex.org/keywords/viral-rebound","display_name":"viral rebound","score":0.5180000066757202},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.7829999923706055},{"id":"https://openalex.org/keywords/advanced-hiv-disease","display_name":"advanced HIV disease","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2780866839","wikidata":"https://www.wikidata.org/wiki/Q2344582","display_name":"Zalcitabine","level":5,"score":0.8583745956420898},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.7782388925552368},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.7690869569778442},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.6363484859466553},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.5898727774620056},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.5718184113502502},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.557520866394043},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5502163171768188},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5040980577468872},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.4949430823326111},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.4904882609844208},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.4700682759284973},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.44766661524772644},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.44277554750442505},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4354393780231476},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.42039138078689575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4177747964859009},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4107535183429718},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37532228231430054},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.3679145574569702},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3525164723396301},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.2300841510295868},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.13916358351707458},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11677378416061401},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.07443255186080933},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016047","descriptor_name":"Zalcitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018414","descriptor_name":"CD8-Positive T-Lymphocytes","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:11322272","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11322272","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Journal Article"},{"id":"pmh:oai:iris.univpm.it:11566/36628","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11566/36628","pdf_url":null,"source":{"id":"https://openalex.org/S4306402571","display_name":"Universit\u00e0 Politecnica delle Marche (Universit\u00e0 Politecnica delle Marche)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I122534668","host_organization_name":"Marche Polytechnic University","host_organization_lineage":["https://openalex.org/I122534668"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:64494153","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11322272","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2152464646","https://openalex.org/W2329393410","https://openalex.org/W2397091212","https://openalex.org/W2129985262","https://openalex.org/W2327970682","https://openalex.org/W3003325034","https://openalex.org/W2317612875","https://openalex.org/W2413299356","https://openalex.org/W2411886522","https://openalex.org/W2328756926"],"abstract_inverted_index":{"In":[0,144],"order":[1],"to":[2,16,29,99,176,186,206,218,229],"test":[3],"the":[4,21,67,100,145,152,190,193,247,252,261,275],"hypothesis":[5],"that":[6],"a":[7,45,80,114,207,278],"combination":[8,300],"of":[9,20,39,77,148,155,192,233,249,251,260,277,283,297,301],"protease":[10,81,302],"inhibitors":[11,303],"with":[12,54,264],"nucleoside":[13,194,305],"analogues-agents":[14],"known":[15],"inhibit":[17],"different":[18],"steps":[19],"human":[22],"immunodeficiency":[23],"virus":[24,201,292],"(HIV)":[25],"life":[26],"cycle--is":[27],"likely":[28],"prove":[30],"more":[31,279],"effective":[32],"in":[33,50,119,246,295,312],"reducing":[34],"viral":[35,272,317],"loads":[36],"than":[37],"either":[38],"those":[40],"modalities":[41],"alone,":[42],"we":[43],"performed":[44],"60":[46],"week,":[47],"open-label":[48],"trial":[49],"32":[51],"HIV-positive":[52],"patients":[53,71,225,263,314],"depressed":[55],"CD4":[56,167,213],"T":[57,214],"lymphocyte":[58,136,215],"cell":[59,105,111,168,180,197],"counts":[60,137,169,181,198,216],"but":[61],"no":[62],"active":[63],"AIDS-defining":[64],"illnesses.":[65],"For":[66],"first":[68],"2":[69,146],"weeks,":[70,211],"received":[72],"600":[73],"mg":[74,86,93],"twice":[75],"daily":[76,89,96],"liquid":[78],"ritonavir,":[79],"inhibitor;":[82],"then":[83],"zidovudine":[84],"200":[85],"three":[87,94],"times":[88,95],"and":[90,130,159,199,290,304,311],"zalcitabine":[91],"0.75":[92],"were":[97,107,138,235,293],"added":[98],"treatment":[101],"regimen.":[102],"Mononuclear":[103],"blood":[104,157],"fractions":[106],"analysed":[108],"for":[109,319],"infected":[110],"levels,":[112],"using":[113],"co-culture":[115],"system.":[116],"HIV-1":[117],"RNA":[118,162],"plasma":[120,160,200,291],"was":[121],"measured":[122],"both":[123,151],"by":[124,140,256],"reverse":[125,131],"transcriptase-polymerase":[126],"chain":[127],"reaction":[128],"(RT-PCR)":[129],"transcriptase":[132],"quantitative":[133],"PCR":[134],"(QcRT-PCR);":[135],"determined":[139],"standard":[141],"laboratory":[142],"methods.":[143],"weeks":[147],"ritonavir":[149,284],"therapy,":[150],"mean":[153],"count":[154],"infectious":[156,196,240,288],"cells":[158,248,289],"HIV":[161,309],"levels":[163],"decreased":[164],"dramatically.":[165],"Mean":[166],"increased":[170],"from":[171,183],"173":[172],"cells/mm3":[173,185],"at":[174,209,267,285],"baseline":[175],"286":[177],"cells/mm3;":[178],"CD8":[179],"rose":[182],"951":[184],"1,141":[187],"cells/mm3.":[188],"With":[189],"introduction":[191,276],"analogues,":[195],"dropped":[202],"another":[203],"log":[204],"unit":[205],"nadir":[208],"8":[210],"while":[212],"continued":[217],"rise":[219],"slowly.":[220],"By":[221],"week":[222,238,257,268,286],"28,":[223],"12":[224],"had":[226,270],"withdrawn":[227],"due":[228],"adverse":[230],"events,":[231],"none":[232],"which":[234],"life-threatening.":[236],"At":[237],"36,":[239],"material":[241],"could":[242],"not":[243],"be":[244],"detected":[245],"10":[250],"17":[253],"remaining":[254],"patients;":[255],"60,":[258],"four":[259],"seven":[262],"residual":[265],"viraemia":[266],"24":[269],"undergone":[271],"relapse.":[273],"After":[274],"palatable":[280],"capsule":[281],"formulation":[282],"52,":[287],"undetectable":[294],"50-60%":[296],"patients.":[298],"The":[299],"analogues":[306],"significantly":[307],"reduces":[308],"load,":[310],"some":[313],"may":[315],"suppress":[316],"activity":[318],"sustained":[320],"periods.":[321]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}